Dividend Gate Capital (DGC), one of Bahrain’s premier investment firms specializing in healthcare, real estate, education and hospitality, has been honored with the prestigious International Finance Award in the category of ‘Most Innovative Healthcare Investment Portfolio 2024.’

This accolade highlights DGC’s excellence in creating a distinguished healthcare investment portfolio, driven by the highest standards of quality and innovation, while achieving exceptional financial outcomes that meet and exceed partner expectations.

The announcement was made during the International Finance Awards ceremony held in Dubai, in the presence of prominent financial institutions, Gulf-based and international banks and industry leaders who gathered to celebrate the financial sector’s achievements in 2024.

Mr. Mohamed Khonji, Founder and Board Member of Dividend Gate Capital, commented, “We are deeply honored to be recognized with this globally acclaimed award. It reflects our commitment to delivering innovative investment solutions that drive impactful change in the healthcare sector. This achievement is a testament to the relentless dedication and efforts of our team in realizing our ambitious vision.”

Mr. Ahmed Al Meer, from the Investment & Strategy department, stated: “This recognition underscores the success in adopting forward-thinking investment strategies within the healthcare sector. We are proud to contribute to this growing sector by supporting innovative solutions and empowering organizations that prioritize patient care and medical advancements. At DGC, our commitment remains steadfast in fostering sustainable growth and driving impactful change within the global healthcare industry.”

 DGC continues to lead in expanding its healthcare investment portfolio, recognizing the sector as a dynamic opportunity for our partners. With growing demand for healthcare services and an evolving market landscape, DGC has strategically partnered with diverse and high-growth institutions, including specialized eye care centers, residency medical examination facilities and polyclinics. These targeted investments not only address pressing healthcare needs but also unlock substantial growth potential for partners.